«From the lab to the patient »
Eclosion provides solutions to transform early stage discoveries all the way into clinical trials, as demonstrated through companies such as GeNeuro and GenKyoTex, which started as academic projects in Eclosion labs in 2004, and are now successful start-ups conducting clinical trials.
| Member since |
25.04.2005 |
| Membership |
Institutional Investor Switzerland |
| Investment strategy |
Early stage |
| Industry and focus |
Biotech & Life Sciences |